Blog*

Dr. Jean-Marc F. Blanchard's picture

Killing Chinese Life Sciences, Part II-Birth, Adolescence, and Adulthood

The most recent and prominent United States (US) attempt to limit cooperation with Chinese life science businesses has stalled, but is hardly dead.

Dr. Jean-Marc F. Blanchard's picture

Killing Chinese Life Sciences, Part I: Poisoning WuXi AppTec and its Kin

In January 2024, Congressman Mike Gallagher, the Chair of the United States (US) House Committee on the Chinese Communist Party, introduced the “Biosecure Act,” which prohibits the US government (USG) from “procuring or obtaining biotechnology equipment or services produced or provided by a biotechnology company of concern,” participating in a c

Dr. Jean-Marc F. Blanchard's picture

The BRI is Dead? Long Live the BRI? Part IV-Bad Flail at the Rail(way) or How Not to Confront the BRI

The Belt and Road Initiative (BRI) has generated so much commentary that it is conceivable that if one printed out all the relevant pages and laid them end-to-end the length might approach that of all the railway track laid under the aegis of the BRI![i] Further commentary seems even m

Dr. Jean-Marc F. Blanchard's picture

The BRI is Dead? Long Live the BRI?, Part III – The Cracked Belts and Forked Roads Blocking Realization of the BRI Dream

China, as you would expect, Belt and Road Initiative (BRI) participants and proponents, and even data support some of the positive sentiment in, if not the logic of, the previous blog in this four-part series on the future of the BRI, which highlighted numerous factors likely to continue propelling the BRI.

Dr. Jean-Marc F. Blanchard's picture

The BRI is Dead? Long Live the BRI?, Part II- Accelerants Allover with Sporadic Retardants

My last blog highlighted the debate raging about the health of China’s Belt and Road Initiative (BRI).[1] It also reviewed the economic and political rationales for China’s ambitious scheme.

Dr. Jean-Marc F. Blanchard's picture

The BRI is Dead? Long Live the BRI? Part I: Present at the Creation

The Belt and Road Initiative (BRI), which consists of two main components, the sea-focused Maritime Silk Road Initiative (MSRI) and the land-focused Silk Road Economic Belt (SREB), came into being in 2013.[1] Since Chinese President Xi Jinping launched the MSRI and the SREB, there has been considerable positive and negative froth about the BRI. Enthusiasts have lauded the BRI as a foundation for building a community of common interests, solving infrastructure gaps in the developing world, helping countries industrialize, expanding people-to-people exchanges, and pluralizing international relations.

Dr. Jean-Marc F. Blanchard's picture

China and IPR, part IV-Innovating Chinese IPR Improvements

This is the last in a four-part series that has looked inter alia at debates surrounding China’s protection of foreign intellectual property (IP) rights (IPR), detailed China’s problematic fulfillment of its IPR commitments, and examined various factors potentially driving China’s poor compliance with its IPR obligations. The focus of this blog is on enumerating a variety of measures that governments and businesses, particularly the former, should embrace to deal with the China challenge to foreign IPR.

Dr. Jean-Marc F. Blanchard's picture

China and IPR, part III-Caring about Causes

In my last blog, I detailed China’s continuing shortcomings with protecting intellectual property (IP) rights (IPR) and the emergence of new challenges. The question arises as to why these problems persist even though it has been more than 20 years since China joined the World Trade Organization (WTO), is a member of numerous IP-focused organizations such as the World Intellectual Property Organization, and faces constant pressure to improve its protection of foreign IP. This blog critically evaluates some of the most common explanations for this state of affairs. Such knowledge is critical for developing realistic business and policy recommendations.

Dr. Jean-Marc F. Blanchard's picture

China and IPR, part II-Patent (Copyright) (Trademark) (Etc.) Facts

This commentary explores China’s fulfillment of its intellectual property (IP) rights (IPR) obligations.[1] Herein, “compliance” requires more than Beijing’s embrace of policies, passage of laws, adoption of regulations, creation of IP administrative entities, or restructuring of its c

Dr. Jean-Marc F. Blanchard's picture

China and IPR, part I-A Persistent Problem with Property?

China’s protection of intellectual property (IP) remains a continuing and serious issue for foreign companies as the United States Trade Representative (USTR) made manifest in its 2021 Section 301 report and 2021 Report to Congress on China’s World Trade Organization (WTO) Compliance and the European Commission conveyed clearly in its 2021 Repor

Pages

*Blogs represent the views of their authors and are not necessarily endorsed by the Wong MNC Center, its Board of Directors, or its Advisory Board. They are intended for the non-commercial use of readers in order to foster debate and discussion and to facilitate and stimulate research.